Mental Health

In the Lab Alia Sajani

How a Baltimore neuroscience study is rewriting Black America’s relationship with medical research

Health tech Mario Aguilar

STAT Plus: Freespira bets on slow and steady, amid spectacular digital health collapses

Health Annalisa Merelli

What’s the evidence for the surgeon general’s proposed social media warning?

Exclusive Olivia Goldhill

STAT Plus: The inside story of how Lykos’ MDMA research went awry

Pharma Meghana Keshavan

STAT Plus: Psychedelics companies see FDA panel’s vote as a growth opportunity, not a roadblock

Health Annalisa Merelli

Withdrawal symptoms hit one in six patients stopping antidepressants, review finds

Pharma Olivia Goldhill and Meghana Keshavan

STAT Plus: FDA advisory panel votes overwhelmingly against MDMA therapy for PTSD

First Opinion Kasley Killam

Shifting the focus from loneliness to social health

Health tech Mario Aguilar

STAT Plus: Akili, maker of a video game to treat ADHD, to be acquired for $34 million

The Readout Elaine Chen

STAT Plus: Wegovy linked to lower risk of alcohol use disorder in real-world study

First Opinion Nadir Al-Saidi

Saving rural psychiatry services will require higher Medicaid payments

The Readout Meghana Keshavan

STAT Plus: More tumult at BIO amid the company’s fourth CEO in four years

Pharma Olivia Goldhill

STAT Plus: After MDMA therapy, she considered suicide. The trial data tell a different story

First Opinion Sadie Elisseou

Addressing health care workers’ trauma can help fight burnout

First Opinion Kay Redfield Jamison

People like me with bipolar disorder must help shape research and clinical care

Health Grace Rubenstein

Mental health crisis centers and EmPATH units: offering care that busy ERs can’t

Letters to the editor Patrick Skerrett

Readers respond to essays on hospital taxes, ADHD in girls and women, and more

The Readout Meghana Keshavan

STAT Plus: Amylyx’s Relvyvrio data was, as promised, disappointing

First Opinion Molly O'Shea

Kids can’t wait any longer for social media safety

First Opinion Wendy K. Chung

Autism doesn’t discriminate. Autism research shouldn’t either

First Opinion Michael Morse and Kathleen Nadeau

ADHD is often overlooked in girls and women. They need help, too

Letters to the editor Patrick Skerrett

Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more

First Opinion Wendy Ward

Mental health screening tools for kids are 30 years out of date

Biotech Andrew Joseph

STAT Plus: Big biotech names roll out Seaport Therapeutics, as interest in neuropsychiatric drugs swells

First Opinion Roy Perlis

The time has come for over-the-counter antidepressants

Health Sarah Owermohle

Your dog is probably on Prozac. Experts say that says more about the American mental health crisis than pets

The Readout Meghana Keshavan

STAT Plus: Lawmakers want to add more Chinese biotechs to defense list

Health tech Mario Aguilar

STAT Plus: Otsuka’s digital treatment for depression cleared by FDA, as pharma tries to crack tricky market

Adam's Take Adam Feuerstein

STAT Plus: A preview of Intra-Cellular Therapies’ depression drug, and sizing up the MASH opportunity